Marchex 10-Q Discloses Material Weakness in Archenia Earn-Out Accounting
MCHX is trading near its 52-week low of $1.15 (13% above the low).
Summary
Marchex's Q3 10-Q confirms the $16.0M revenue and $1.3M net income already reported November 10, but newly discloses a material weakness in contingent earn-out accounting tied to the Archenia deal, with cash down to $8.7M from $10.3M at year-end.
Key Events · Earnings and Guidance · MCHX
-
Material Weakness Disclosed
Management concluded disclosure controls and procedures were not effective due to a material weakness related to a calculation error in the contingent earn-out consideration associated with the Archenia SPA; remediation is underway.
-
Q3 Results Confirmed
Revenue of $15.974M versus $15.192M a year ago, and net income of $1.274M versus a $1.293M loss — figures already released November 10.
-
Balance Sheet Levered Up
Total liabilities rose to $26.593M from $13.895M at December 31, 2025, driven by $10.0M of 6% convertible notes convertible at $1.80 per share and a $4.5M contingent earn-out liability.
-
Cash Burn Continues
Cash and equivalents fell to $8.671M from $10.301M at year-end, with $0.734M used in operating activities over the nine months; management says resources fund operations for at least twelve months.
Analysis · MCHX · Technology
The headline numbers were already out on November 10 — Q3 revenue of $16.0M and net income of $1.3M — but the full 10-Q carries something the press release did not: management concluded disclosure controls were not effective because of a material weakness in how the Archenia contingent earn-out was calculated. That is a first-time governance disclosure on a company that just closed a related-party acquisition, and it lands alongside a balance sheet that has gotten heavier: total liabilities rose to $26.6M from $13.9M at year-end as the $10.0M convertible notes and $4.5M earn-out liability came on, while cash fell to $8.7M from $10.3M. The company still says its resources fund operations for at least twelve months, but the margin for error is thinner and the accounting control gap is exactly the kind of thing that raises the cost of any future capital raise.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MCHX was trading at $1.30 on NASDAQ in the Technology sector, with a market capitalization of approximately $57.6M. The 52-week trading range was $1.15 to $2.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.